Abstract
Functional imaging allows the quantification of biochemical or biophysiological changes in-vivo through the visualization of the spatial distribution and temporal changes of administrated radiopharmaceuticals. Instrumentation advances such as PET-CT (positron emission tomography - computed tomography) and PET-MR (positron emission tomography - magnetic resonance), improvements in image processing and reconstruction, the development of target and disease-specific radiotracers and improved kinetic modelling techniques, have substantially enhanced our ability to measure functional changes in normal and diseased states. Various combinations of these advances and refinements are now used in routine clinical practice for patient care. In this paper we review recent literature on software developments and applications in image restoration, motion correction, kinetic analysis, and image processing in the field of functional imaging.
Keywords: PET, SPECT, image correction, kinetic modelling, motion correction, PET-CT (positron emission tomography - computed tomography), PET-MR (positron emission tomography - magnetic resonance), disease-specific radiotracers, kinetic modelling techniques
Current Pharmaceutical Biotechnology
Title:Recent Software Developments and Applications in Functional Imaging
Volume: 13 Issue: 11
Author(s): Lingfeng Wen, Stefan Eberl, Michael Fulham and (David) Dagan Feng
Affiliation:
Keywords: PET, SPECT, image correction, kinetic modelling, motion correction, PET-CT (positron emission tomography - computed tomography), PET-MR (positron emission tomography - magnetic resonance), disease-specific radiotracers, kinetic modelling techniques
Abstract: Functional imaging allows the quantification of biochemical or biophysiological changes in-vivo through the visualization of the spatial distribution and temporal changes of administrated radiopharmaceuticals. Instrumentation advances such as PET-CT (positron emission tomography - computed tomography) and PET-MR (positron emission tomography - magnetic resonance), improvements in image processing and reconstruction, the development of target and disease-specific radiotracers and improved kinetic modelling techniques, have substantially enhanced our ability to measure functional changes in normal and diseased states. Various combinations of these advances and refinements are now used in routine clinical practice for patient care. In this paper we review recent literature on software developments and applications in image restoration, motion correction, kinetic analysis, and image processing in the field of functional imaging.
Export Options
About this article
Cite this article as:
Wen Lingfeng, Eberl Stefan, Fulham Michael and Dagan Feng (David), Recent Software Developments and Applications in Functional Imaging, Current Pharmaceutical Biotechnology 2012; 13 (11) . https://dx.doi.org/10.2174/138920112802502015
DOI https://dx.doi.org/10.2174/138920112802502015 |
Print ISSN 1389-2010 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4316 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Pharmacogenetics of Non-small Cell Lung Cancer (NSCLC): Time to "Work it Out"?
Current Pharmaceutical Design Trends in Malignant Glioma Monoclonal Antibody Therapy
Current Cancer Therapy Reviews Chemoresistance in High-Grade Gliomas: Relevance of Adenosine Signalling in Stem-Like Cells of Glioblastoma Multiforme
Current Drug Targets The Role of EGFR-Met Interactions in the Pathogenesis of Glioblastoma and Resistance to Treatment
Current Cancer Drug Targets Targeted Therapy for Glioblastoma: Lessons Learned and Future Directions
Current Cancer Therapy Reviews Human Amnion–Derived Cells as a Reliable Source of Stem Cells
Current Molecular Medicine Plants vs. Cancer: A Review on Natural Phytochemicals in Preventing and Treating Cancers and Their Druggability
Anti-Cancer Agents in Medicinal Chemistry Induced pluripotent stem cell-derived mesenchymal stem cells: A leap toward personalized therapies.
Current Stem Cell Research & Therapy Recent Progress in the Development of Fluorometric Chemosensors to Detect Enzymatic Activity
Current Medicinal Chemistry Inhibitors of Cancer Stem Cells
Anti-Cancer Agents in Medicinal Chemistry The Phosphoinositide 3-Kinase Pathway in Human Cancer: Genetic Alterations and Therapeutic Implications
Current Genomics Induction of Apoptosis in Macrophages via Kv1.3 and Kv1.5 Potassium Channels
Current Medicinal Chemistry Targeting PPARalpha in Alzheimer's Disease
Current Alzheimer Research Production of Alpha Emitters for Targeted Alpha Therapy
Current Radiopharmaceuticals Left-Right Asymmetry in Embryonic Development and Breast Cancer: Common Molecular Determinants?
Current Medicinal Chemistry CD44 and EpCAM: Cancer-Initiating Cell Markers
Current Molecular Medicine Anti-Apoptotic Mechanisms of Drug Resistance in Cancer
Current Cancer Drug Targets Recent Clinical Experience with Oncolytic Viruses
Current Pharmaceutical Biotechnology Tumor Protein p63/microRNA Network in Epithelial Cancer Cells
Current Genomics Therapy for Dominant Inherited Diseases by Allele-Specific RNA Interference: Successes and Pitfalls
Current Gene Therapy